4//SEC Filing
Tesi Raymond Joseph 4
Accession 0001213900-21-036352
CIK 0001711754other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 4:06 PM ET
Size
7.3 KB
Accession
0001213900-21-036352
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Tesi Raymond Joseph
DirectorPresident & CEO10% Owner
Transactions
- Sale
Common Stock
2021-07-07$20.02/sh−5,649$113,082→ 1,535,284 total - Sale
Common Stock
2021-07-08$20.08/sh−24,351$488,968→ 1,510,933 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.04, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.21, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above.
Documents
Issuer
Inmune Bio, Inc.
CIK 0001711754
Entity typeother
Related Parties
1- filerCIK 0001767280
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 4:06 PM ET
- Size
- 7.3 KB